Reuters has reported on the US Food and Drug Administration that is expected to soon announce new, more stringent standards for an emergency authorization of a COVID-19 vaccine. The article explained that lowering the chances that one might be cleared for use before the Nov. 3 election. Reuters was acknowlding the Washington Post reporting this on Tuesday. The agency is issuing the guidance to boost transparency and public trust as health experts have become increasingly concerned that the Trump administration might be interfering in the approval process, the newspaper said. According to the report, the FDA is expected to ask vaccine manufacturers seeking an emergency authorization to follow trial participants for a median of at least two months after they receive a second vaccine shot. It also said the agency is asking that trials identify a specific number of severe cases of COVID-19 in patients who received a placebo in the trials. Market implications US stocks are dependent on vaccine sentiment and stimulus. The stalemate in Congress over the size and shape of another coronavirus-response bill will continue to dent hopes of a swift economic recovery and weigh on stocks. FX Street FX Street FXStreet is the leading independent portal dedicated to the Foreign Exchange (Forex) market. It was launched in 2000 and the portal has always been proud of their unyielding commitment to provide objective and unbiased information, to enable their users to take better and more confident decisions. View All Post By FX Street FXStreet News share Read Next RBNZ leaves OCR unchanged at 0.25%, maintains QE at NZD100 billion FX Street 2 years Reuters has reported on the US Food and Drug Administration that is expected to soon announce new, more stringent standards for an emergency authorization of a COVID-19 vaccine. The article explained that lowering the chances that one might be cleared for use before the Nov. 3 election. Reuters was acknowlding the Washington Post reporting this on Tuesday. The agency is issuing the guidance to boost transparency and public trust as health experts have become increasingly concerned that the Trump administration might be interfering in the approval process, the newspaper said. According to the report, the FDA is expected to ask vaccine manufacturers seeking an… Regulated Forex Brokers All Brokers Sponsored Brokers Broker Benefits Min Deposit Score Visit Broker 1 $100T&Cs Apply 0% Commission and No stamp DutyRegulated by US,UK & International StockCopy Successfull Traders 9.8 Visit Site FreeBets Reviews$100Your capital is at risk. 2 T&Cs Apply 9.8 Visit Site FreeBets Reviews$100Your capital is at risk. 3 Recommended Broker $100T&Cs Apply No deposit or withdrawal feesTrade major forex pairs such as EUR/USD with leverage up to 30:1 and tight spreads of 0.9 pips Low $100 minimum deposit to open a trading account 9 Visit Site FreeBets ReviewsYour capital is at risk. 4 T&Cs Apply Visit Site FreeBets ReviewsYour capital is at risk. 5 Recommended Broker $0T&Cs Apply Trade gold, silver, and platinum directly against major currenciesUp to 1:500 leverage for forex trading24/5 customer service by phone and email 9 Visit Site FreeBets ReviewsYour capital is at risk.
